Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gevers

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
JHEP Reports : Innovation in Hepatology|July 18, 2025
Phosphatidylethanol and ethyl glucuronide to categorize alcohol consumption in alcohol-related cirrhosisBenedict T K Vanlerberghe, Catalina Dumitrascu, Nele Van den Eede, et al.
The Netherlands Journal of Medicine|July 19, 2018
Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver diseaseM A Lantinga, R G L de Sévaux, T J G Gevers, et al.
Journal of Hepatology|January 23, 2022
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis GroupSimon Pape, Romée J A L M Snijders, Tom J G Gevers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 10, 2019
Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune HepatitisSimon Pape, Tom J G Gevers, Michail Belias, et al.
American Journal of Nephrology|September 8, 2017
The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney DiseaseHedwig M A D'Agnolo, Niek F Casteleijn, Tom J G Gevers, et al.
NPJ Digital Medicine|July 18, 2025
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT modelGiorgio Cazzaniga, Vincenzo L'Imperio, Emanuela Bonoldi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2023
Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitisSusan E Fischer, Elsemieke S de Vries, Maarten E Tushuizen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2019
Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 MonthsSimon Pape, Tom J G Gevers, Jan Maarten Vrolijk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 16, 2020
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiationSimon Pape, Tom J G Gevers, Jan Maarten Vrolijk, et al.
Frontiers in Immunology|January 25, 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver diseaseLorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
JHEP Reports : Innovation in Hepatology|July 18, 2025
Phosphatidylethanol and ethyl glucuronide to categorize alcohol consumption in alcohol-related cirrhosisBenedict T K Vanlerberghe, Catalina Dumitrascu, Nele Van den Eede, et al.
The Netherlands Journal of Medicine|July 19, 2018
Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver diseaseM A Lantinga, R G L de Sévaux, T J G Gevers, et al.
Journal of Hepatology|January 23, 2022
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis GroupSimon Pape, Romée J A L M Snijders, Tom J G Gevers, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 10, 2019
Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune HepatitisSimon Pape, Tom J G Gevers, Michail Belias, et al.
American Journal of Nephrology|September 8, 2017
The Association of Combined Total Kidney and Liver Volume with Pain and Gastrointestinal Symptoms in Patients with Later Stage Autosomal Dominant Polycystic Kidney DiseaseHedwig M A D'Agnolo, Niek F Casteleijn, Tom J G Gevers, et al.
NPJ Digital Medicine|July 18, 2025
Automating liver biopsy segmentation with a robust, open-source tool for pathology research: the HOTSPoT modelGiorgio Cazzaniga, Vincenzo L'Imperio, Emanuela Bonoldi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2023
Importance of complete response for outcomes of pregnancy in patients with autoimmune hepatitisSusan E Fischer, Elsemieke S de Vries, Maarten E Tushuizen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2019
Rapid Response to Treatment of Autoimmune Hepatitis Associated With Remission at 6 and 12 MonthsSimon Pape, Tom J G Gevers, Jan Maarten Vrolijk, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 16, 2020
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiationSimon Pape, Tom J G Gevers, Jan Maarten Vrolijk, et al.
Frontiers in Immunology|January 25, 2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver diseaseLorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, et al.
Pageof 10